Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities.

MLA

Brown, Emily, et al. “Weight Loss Variability with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus and Obesity: Mechanistic Possibilities.” Obesity Reviews : An Official Journal of the International Association for the Study of Obesity, vol. 20, no. 6, June 2019, pp. 816–28. EBSCOhost, https://doi.org/10.1111/obr.12841.

APA

Brown, E., Wilding, J. P. H., Barber, T. M., Alam, U., & Cuthbertson, D. J. (2019). Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities. Obesity Reviews : An Official Journal of the International Association for the Study of Obesity, 20(6), 816–828. https://doi.org/10.1111/obr.12841

Chicago

Brown, Emily, John P H Wilding, Thomas M Barber, Uazman Alam, and Daniel J Cuthbertson. 2019. “Weight Loss Variability with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus and Obesity: Mechanistic Possibilities.” Obesity Reviews : An Official Journal of the International Association for the Study of Obesity 20 (6): 816–28. doi:10.1111/obr.12841.